One valid point is that some additional information and guidance should have been given regarding sales. When you announce $17 million dollars in orders and your market cap is $5 million that's a significant development. Now without guidance we don't know if those orders are front loaded or will take time to gradually ramp up and without that guidance one would normally assume that means the second quarter revenue will be in the seven figures and they will make $8. 5 million or more in sales for 2017. If that assumption is realistic and what the company expects then not much harm done but setting up for disappointment if revenue isn't close to $9 millions for 2017. The street apparently doesn't believe those sales #'s judging from the share price.
The retirement of someone at 70 is a non issue, I doubt I will be working past 70.
(3)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links